Aandeel JAGSNPHARM JAGSONPAL PHARMACEUTICALS LIMITED
Toevoegen aan een lijst
Om deze functie te gebruiken moet u een klant of lid zijn.
InloggenRegistreren

Andere talen Jagsonpal Pharmaceuticals Limited

Aandelen

JAGSNPHARM

INE048B01027

Vertraagde tijd NSE India S.E.
Andere beurzen
 07:42:56 26-04-2024 		Variatie 5 dagen Verschil t.o.v. 1 jan (%)
339,4 INR +1,81% Intraday-grafiek van Jagsonpal Pharmaceuticals Limited +6,73% -12,68%
08/03 Jagsonpal Pharmaceuticals Limited lanceert Queezy-ER® CI
02/02 Jagsonpal Pharmaceuticals Limited rapporteert resultaten voor het derde kwartaal en de negen maanden eindigend op 31 december 2023 CI

Andere talen

Zoeken op
Resultaten bekijken
Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!
Gratis inschrijven
Jagsonpal Pharmaceuticals Limited Launches Queezy-ER®
Jagsonpal Pharmaceuticals Limited Announces Chief Financial Officer Changes
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023
Jagsonpal Pharmaceuticals' Net Profit Soars in Fiscal Q1
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023
Jagsonpal Pharmaceuticals Limited Recommends Dividend for the Financial Year Ended March 31, 2023
Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm and others completed the acquisition of 43.73% stake in Jagsonpal Pharmaceuticals Limited from Aresko Progressive Private Limited and Rajpal Singh Kochhar.
Jagsonpal Pharmaceuticals Limited Announces Appointment of Abhishek Joshi as Company Secretary and Compliance Officer
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022
Jagsonpal Pharmaceuticals Limited Announces Executive Changes
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
Jagsonpal Pharmaceuticals : ESOP/ESPS/SBEB Scheme
Jagsonpal Pharmaceuticals : Reply to Clarification Sought
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022
Jagsonpal Pharmaceuticals : Appointment
Jagsonpal Pharmaceuticals Limited Announces Executive Changes
Infinity Holdings Sidecar I and Infinity Holdings, managed by Infinity Investment Management, Investment Arm cancelled the acquisition of 26% stake in Jagsonpal Pharmaceuticals Limited.
Jagsonpal Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022
Geen resultaten voor deze zoekopdracht
Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Filters

Zoeken op

Datum van publicatie

Sinds de

Tot

  1. Beurs
  2. Aandelen
  3. Koers JAGSNPHARM
  4. Nieuws Jagsonpal Pharmaceuticals Limited
  5. Andere talen